Market Research Logo

Pharmaceuticals in India

Pharmaceuticals in India

Summary

Pharmaceuticals in India industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the India pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key highlights

  • The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
  • The Indian pharmaceuticals market had total revenues of $35.2bn in 2017, representing a compound annual growth rate (CAGR) of 15.9% between 2013 and 2017.
  • One unique characteristic of the market is that the priorities of consumers in developing countries can be focused in different areas than expected, and this entirely changes how companies have to do business.
  • Bourgeoning middle class households, coupled with improvements in medical infrastructure and the increased penetration of health insurance in the country has driven growth in the India pharmaceuticals market.
Scope
  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in India
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in India
  • Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the India pharmaceuticals market with five year forecasts
Reasons to buy
  • What was the size of the India pharmaceuticals market by value in 2017?
  • What will be the size of the India pharmaceuticals market in 2022?
  • What factors are affecting the strength of competition in the India pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitiors in India's pharmaceuticals market?


Executive Summary
Market value
Market value forecast
Geography segmentation
Market share
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Geography segmentation
Market share
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Aurobindo Pharma Limited
Dr. Reddy's Laboratories Limited
Lupin Limited
Sun Pharmaceutical Industries Limited
Macroeconomic Indicators
Country data
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine
List of Tables
Table 1: India pharmaceuticals market value: $ billion, 2013-17
Table 2: India pharmaceuticals market geography segmentation: $ billion, 2017
Table 3: India pharmaceuticals market share: % share, by value, 2017
Table 4: India pharmaceuticals market value forecast: $ billion, 2017-22
Table 5: Aurobindo Pharma Limited: key facts
Table 6: Aurobindo Pharma Limited: key financials ($)
Table 7: Aurobindo Pharma Limited: key financials (A$)
Table 8: Aurobindo Pharma Limited: key financial ratios
Table 9: Dr. Reddy's Laboratories Limited: key facts
Table 10: Dr. Reddy's Laboratories Limited: key financials ($)
Table 11: Dr. Reddy's Laboratories Limited: key financials (Rs.)
Table 12: Dr. Reddy's Laboratories Limited: key financial ratios
Table 13: Lupin Limited: key facts
Table 14: Lupin Limited: key financials ($)
Table 15: Lupin Limited: key financials (Rs.)
Table 16: Lupin Limited: key financial ratios
Table 17: Sun Pharmaceutical Industries Limited: key facts
Table 18: Sun Pharmaceutical Industries Limited: key financials ($)
Table 19: Sun Pharmaceutical Industries Limited: key financials (Rs.)
Table 20: Sun Pharmaceutical Industries Limited: key financial ratios
Table 21: India size of population (million), 2013-17
Table 22: India gdp (constant 2005 prices, $ billion), 2013-17
Table 23: India gdp (current prices, $ billion), 2013-17
Table 24: India inflation, 2013-17
Table 25: India consumer price index (absolute), 2013-17
Table 26: India exchange rate, 2013-17
List of Figures
Figure 1: India pharmaceuticals market value: $ billion, 2013-17
Figure 2: India pharmaceuticals market geography segmentation: % share, by value, 2017
Figure 3: India pharmaceuticals market share: % share, by value, 2017
Figure 4: India pharmaceuticals market value forecast: $ billion, 2017-22
Figure 5: Forces driving competition in the pharmaceuticals market in India, 2017
Figure 6: Drivers of buyer power in the pharmaceuticals market in India, 2017
Figure 7: Drivers of supplier power in the pharmaceuticals market in India, 2017
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in India, 2017
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in India, 2017
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in India, 2017
Figure 11: Aurobindo Pharma Limited: revenues & profitability
Figure 12: Aurobindo Pharma Limited: assets & liabilities
Figure 13: Dr. Reddy's Laboratories Limited: revenues & profitability
Figure 14: Dr. Reddy's Laboratories Limited: assets & liabilities
Figure 15: Lupin Limited: revenues & profitability
Figure 16: Lupin Limited: assets & liabilities
Figure 17: Sun Pharmaceutical Industries Limited: revenues & profitability
Figure 18: Sun Pharmaceutical Industries Limited: assets & liabilities

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report